Literature DB >> 29737570

MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.

Chundi Gao1, Chao Zhou2,3, Jing Zhuang2,3, Lijuan Liu2,3, Cun Liu1, Huayao Li1, Gongxi Liu2,3, Junyu Wei2,3, Changgang Sun3.   

Abstract

Growing evidence has shown that a large number of miRNAs are abnormally expressed in cervical cancer (CC) tissues and play irreplaceable roles in tumorigenesis, progression, and metastasis. This study aimed to identify new biomarkers and pivotal genes associated with CC prognosis through comprehensive bioinformatics analysis. At first, the data of gene expression microarray (GSE30656) was downloaded from GEO database and differential miRNAs were obtained. Additionally, 4 miRNAs associated with the survival time of patients with CC were screened through TCGA differential data analysis, Kaplan-Meier, and Landmark analysis. Among them, the low expression of miR-188 and high expression of miR-223 correlated with the short survival of CC patients, while the down-regulation of miR-99a and miR-125b was closely related to the 5-year survival rate of patients. Then, based on the correspondence between the differentially expressed genes (DEGs) in CC from the TCGA data and the 4 miRNAs target genes, 58 target genes were screened to perform the analysis of function enrichment and the visualization of protein-protein interaction (PPI) networks. The seven pivotal genes of the PPI network as the target genes of four miRNAs related to prognosis, they were directly or indirectly involved in the development of CC. In this study, based on high-throughput data mining, differentially expressed miRNAs and related target genes were analyzed to provide an effective bioinformatics basis for further understanding of the pathogenesis and prognosis of CC. And the results may be a promising biomarker for the early screening of high-risk populations and early diagnosis of cervical cancer.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  bioinformatics analysis; cervical cancer; miRNA; subsistence analysis; target genes

Mesh:

Substances:

Year:  2018        PMID: 29737570     DOI: 10.1002/jcb.27029

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  32 in total

1.  miR-188-5p promotes oxaliplatin resistance by targeting RASA1 in colon cancer cells.

Authors:  Xijia Zhu; Xishun Luo; Zhike Song; Shiyu Jiang; Xiangkai Long; Xueyuan Gao; Xinyang Xie; Laijian Zheng; Haipeng Wang
Journal:  Oncol Lett       Date:  2021-04-20       Impact factor: 2.967

2.  Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.

Authors:  Li-Li Jiang; De-Ming Tong; Zi-Yi Feng; Kui-Ran Liu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

3.  MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer.

Authors:  Jingli Wu; Yuying Zhao; Fenglian Li; Baohua Qiao
Journal:  J Physiol Biochem       Date:  2019-04-23       Impact factor: 4.158

4.  Down-regulated expression of miR-99a is associated with lymph node metastasis and predicts poor outcome in stage IB cervical squamous cell carcinoma: a case-control study.

Authors:  Gongyi Zhang; Rong Zhang; Ping Bai; Shumin Li; Jing Zuo; Yuanyuan Zhang; Mei Liu; Lingying Wu
Journal:  Ann Transl Med       Date:  2022-06

5.  miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD.

Authors:  Gang Wang; Yu Lu; Shi Di; Maohua Xie; Fang Jing; Xiaoyan Dai
Journal:  Oncol Lett       Date:  2022-05-27       Impact factor: 3.111

Review 6.  The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.

Authors:  Yaheng Li; Chuanyin Li; Shuyuan Liu; Jia Yang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

Review 7.  Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.

Authors:  Michela Lucia Sammarco; Manuela Tamburro; Alessandra Pulliero; Alberto Izzotti; Giancarlo Ripabelli
Journal:  Microrna       Date:  2020

8.  Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer.

Authors:  Shangdan Xie; Shuya Pan; Shuangwei Zou; Haiyan Zhu; Xueqiong Zhu
Journal:  Clin Interv Aging       Date:  2020-06-03       Impact factor: 4.458

9.  EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.

Authors:  Juanhong Zhao; Haixia Li; Miao Yuan
Journal:  Genes Genomics       Date:  2021-03-09       Impact factor: 1.839

10.  Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer.

Authors:  Dan Meng; Hua Jin; Yun Gu; Shizhi Wang; Xing Zhang; Wenjing Yan; Qianqian Xia; Siyuan Shen; Shuqian Xie; Mengjing Cui; Bo Ding
Journal:  Cancer Cell Int       Date:  2021-07-08       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.